Consequently, we and others previously demonstrated that targeting STAT3 by upstream signaling inhibitors of the STAT3 pathway or by genetic depletion decreases glioma cell proliferation and migration in vitro and prolongs overall survival of tumor-bearing mice in vivo [15,16,17,18,19,20,21]. The gene discussed is STAT3; the disease is central nervous system cancer.